Evidence map›Paper›PMID 26605291›Full record

ArticleAnnals of translational medicine2015

Mucin1 expression in focal epidermal dysplasia of actinic keratosis.

Enrique Arciniegas, Luz Marina Carrillo, Héctor Rojas, Richard Ramírez, Oscar Reyes, Ambar Suárez, Fabiana Ortega

Abstract read
In one paragraph

Article in Annals of translational medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Enrique Arciniegas1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Luz Marina Carrillo1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Héctor Rojas1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Richard Ramírez1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Oscar Reyes1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Ambar Suárez1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Fabiana Ortega1 Instituto de Biomedicina, 2 Servicio Autónomo Instituto de Biomedicina, 3 Instituto de Inmunología, Universidad Central de Venezuela, Caracas, República Bolivariana de Venezuela.
Central University of Venezuela · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActinic keratoses (AKs) are generally considered as premalignant skin lesions that can progress into squamous cell carcinoma (SCC) in situ and invasive SCC. However, its progression to SCC is still matter of debate. A transmembrane glycoprotein that contributes to the progression of certain premalignant and malignant lesions is mucin1 (MUC1). Nevertheless, their functions in the skin lesions are not yet fully clear. Therefore, the aim of this study is to ascertain whether MUC1 is present in the focal epidermal dysplasia of AK.

methodsFourteen skin biopsies from patients diagnosed with AK were selected. They were classified according to the degree of dysplasia in keratinocyte intraepidermal neoplasia (KIN) I, KIN II, and KIN III. In five biopsies the three degrees were present, in two biopsies both KIN I and KIN II, in four biopsies only KIN I, and in three biopsies only KIN III. The presence of MUC1 was assessed by immunofluorescence staining using confocal laser scanning microscopy.

resultsImmunostaining revealed that MUC1 was present over the entire cell surface of only a few atypical basal keratinocytes confined to the lower third of the epidermis (KIN I). While in KIN II where atypical keratinocytes occupy the lower two thirds, MUC1 was localized at the apical surface of some atypical keratinocytes and over the entire cell surface of some of them. Interestingly, in KIN III where the atypical keratinocytes extend throughout the full thickness, MUC1 was localized at the apical surface and over the entire cell surface of many of these cells. Conversely, MUC1 expression was not detected in the epidermis of normal skin.

conclusionsOur findings suggest that the expression of MUC1 in AK would be induced by alteration of keratinocyte stratification and differentiation and associated to the degree of dysplasia rather than the thickness of the epidermis.

Indexed as

actinic keratosis (AK)atypical keratinocytesexpansive growthkeratinocyte intraepidermal neoplasia (KIN)Mucin1 (MUC1)

Identifiers

PMID26605291
PMCPMC4620102
OpenAlexW1841088979

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.